HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma

Liu Li; Kuang Tianrui; Li Chunlei; Qiu Zhendong; Chen Xiaoyan; Deng Wenhong

doi:doi:10.18632/aging.204925

← Back

Research Paper Volume 15, Issue 16 pp 7997—8012

HYDIN mutation status as a potential predictor of immune checkpoint inhibitor efficacy in melanoma

Figure 6. GSEA enrichment analysis between HYDIN-MUT and HYDIN-WT. (A) KEGG enrichment analysis. (B) Reactome enrichment analysis. (C, D) GO-BP enrichment analysis.